Cargando…
Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies
Multiple sclerosis (MS) therapy has evolved rapidly with an increased availability of several immunomodulating therapies over the past two decades. Disease-modifying therapies have proven to be effective in treating relapse–remitting MS (RRMS). However, clinical trials involving some of the same age...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053100/ https://www.ncbi.nlm.nih.gov/pubmed/30050376 http://dx.doi.org/10.2147/DNND.S100096 |